ArticleJournal of internal medicine2026

Janus kinase and calcineurin-inhibitor combination in anti-MDA5 dermatomyositis: No significant survival benefit but reassuring safety profile.

Valentine Pagis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.